PROS1 and COVID-19: We next evaluated the antigenicity of the four versions of the S proteins by WB and ELISA using a panel of six COVID-19 convalescent human sera, collected from COVID-19 patients after they had recovered from the disease in the First Affiliated Hospital of Xiamen University, China.